These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20558292)

  • 1. ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
    Schmeding M; Kienlein S; Röcken C; Neuhaus R; Neuhaus P; Heidenhain C; Neumann UP
    Transpl Immunol; 2010 Aug; 23(4):156-60. PubMed ID: 20558292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
    Jain A; Ryan C; Mohanka R; Orloff M; Abt P; Romano J; Bryan L; Batzold P; Mantry P; Bozorgzadeh A
    Clin Transplant; 2006; 20(5):624-33. PubMed ID: 16968489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence.
    Schmeding M; Dankof A; Krenn V; Krukemeyer MG; Koch M; Spinelli A; Langrehr JM; Neumann UP; Neuhaus P
    Am J Transplant; 2006 Mar; 6(3):523-30. PubMed ID: 16468961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C4d in acute rejection after liver transplantation and its usefulness in differential diagnosis between acute liver rejection and hepatitis C recurrence.
    Gierej B; Kobryń K; Gierej P; Górnicka B
    Ann Transplant; 2014 Aug; 19():373-81. PubMed ID: 25082343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.
    Song AT; Mello ES; Alves VA; Cavalheiro Nde P; Melo CE; Bonazzi PR; Tengan FM; Freire MP; Barone AA; D'Albuquerque LA; Abdala E
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):56-64. PubMed ID: 25742264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4d: a marker for hepatic transplant rejection.
    Lorho R; Turlin B; Aqodad N; Triki N; de Lajarte-Thirouard AS; Camus C; Lakehal M; Compagnon P; Dupont-Bierre E; Meunier B; Boudjema K; Messner M
    Transplant Proc; 2006 Sep; 38(7):2333-4. PubMed ID: 16980082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ; Aardema KL; Burd EM; Nakhleh RE; Brown KA; Abouljoud MS; Hirst K; Moonka DK
    Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases.
    Bouron-Dal Soglio D; Rougemont AL; Herzog D; Soucy G; Alvarez F; Fournet JC
    Hum Pathol; 2008 Jul; 39(7):1103-10. PubMed ID: 18570976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation.
    MacQuillan GC; de Boer WB; Allan JE; Platten MA; Reed WD; Jeffrey GP
    Clin Transplant; 2010; 24(2):252-8. PubMed ID: 19712085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of C4d deposit in post liver transplant liver biopsies.
    Fayek SA
    Transpl Immunol; 2012 Dec; 27(4):166-70. PubMed ID: 22975227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
    Haga H; Egawa H; Fujimoto Y; Ueda M; Miyagawa-Hayashino A; Sakurai T; Okuno T; Koyanagi I; Takada Y; Manabe T
    Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current views on rejection pathology in liver transplantation.
    Neil DA; Hübscher SG
    Transpl Int; 2010 Oct; 23(10):971-83. PubMed ID: 20723179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.
    Martelius T; Halme L; Arola J; Höckerstedt K; Lautenschlager I
    Transpl Immunol; 2009 Sep; 21(4):244-6. PubMed ID: 19540918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
    Kozlowski T; Andreoni K; Schmitz J; Hayashi PH; Nickeleit V
    Liver Transpl; 2012 Jun; 18(6):641-58. PubMed ID: 22298469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
    Regev A; Molina E; Moura R; Bejarano PA; Khaled A; Ruiz P; Arheart K; Berho M; Drachenberg CB; Mendez P; O'Brien C; Jeffers L; Tzakis A; Schiff ER
    Liver Transpl; 2004 Oct; 10(10):1233-9. PubMed ID: 15376303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
    Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.